{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:05:19Z","timestamp":1769501119453,"version":"3.49.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T00:00:00Z","timestamp":1529280000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s00330-018-5556-2","type":"journal-article","created":{"date-parts":[[2018,6,18]],"date-time":"2018-06-18T15:25:51Z","timestamp":1529335551000},"page":"450-457","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Diagnosis of diffuse spleen involvement in haematological malignancies using a spleen-to-liver attenuation ratio on contrast-enhanced CT images"],"prefix":"10.1007","volume":"29","author":[{"given":"Christian Philipp","family":"Reinert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clemens","family":"Hinterleitner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan","family":"Fritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marius","family":"Horger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,6,18]]},"reference":[{"key":"5556_CR1","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1200\/JCO.1990.8.9.1598","volume":"8","author":"CL Olweny","year":"1990","unstructured":"Olweny CL (1990) Cotswolds modification of the Ann Arbor staging system for Hodgkin's disease. J Clin Oncol 8:1598","journal-title":"J Clin Oncol"},{"key":"5556_CR2","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1053\/j.sult.2006.10.010","volume":"28","author":"K Bhatia","year":"2007","unstructured":"Bhatia K, Sahdev A, Reznek RH (2007) Lymphoma of the spleen. Semin Ultrasound CT MR 28:12\u201320","journal-title":"Semin Ultrasound CT MR"},{"key":"5556_CR3","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1259\/bjr\/31542964","volume":"85","author":"SS Saboo","year":"2012","unstructured":"Saboo SS, Krajewski KM, O'Regan KN et al (2012) Spleen in haematological malignancies: spectrum of imaging findings. Br J Radiol 85:81\u201392","journal-title":"Br J Radiol"},{"key":"5556_CR4","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1148\/rg.276065170","volume":"27","author":"NP Leite","year":"2007","unstructured":"Leite NP, Kased N, Hanna RF et al (2007) Cross-sectional imaging of extranodal involvement in abdominopelvic lymphoproliferative malignancies. Radiographics 27:1613\u20131634","journal-title":"Radiographics"},{"key":"5556_CR5","doi-asserted-by":"publisher","first-page":"W91","DOI":"10.2214\/AJR.09.2637","volume":"194","author":"CG Cronin","year":"2010","unstructured":"Cronin CG, Swords R, Truong MT et al (2010) Clinical utility of PET\/CT in lymphoma. AJR Am J Roentgenol 194:W91\u2013w103","journal-title":"AJR Am J Roentgenol"},{"key":"5556_CR6","doi-asserted-by":"publisher","first-page":"745","DOI":"10.2214\/AJR.08.1160","volume":"192","author":"PA Jong de","year":"2009","unstructured":"de Jong PA, van Ufford HM, Baarslag HJ et al (2009) CT and 18F-FDG PET for noninvasive detection of splenic involvement in patients with malignant lymphoma. AJR Am J Roentgenol 192:745\u2013753","journal-title":"AJR Am J Roentgenol"},{"key":"5556_CR7","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1159\/000070290","volume":"64","author":"M Hoffmann","year":"2003","unstructured":"Hoffmann M, Kletter K, Becherer A, Jager U, Chott A, Raderer M (2003) 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) for staging and follow-up of marginal zone B-cell lymphoma. Oncology 64:336\u2013340","journal-title":"Oncology"},{"key":"5556_CR8","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME et al (2007) Revised response criteria for malignant lymphoma. J Clin Oncol 25:579\u2013586","journal-title":"J Clin Oncol"},{"key":"5556_CR9","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1200\/JCO.2006.08.2305","volume":"25","author":"ME Juweid","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS et al (2007) Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571\u2013578","journal-title":"J Clin Oncol"},{"key":"5556_CR10","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1080\/10245332.2017.1312088","volume":"22","author":"S Nakachi","year":"2017","unstructured":"Nakachi S, Okada M, Morishima S et al (2017) Clinical usefulness of FDG-PET\/CT for the evaluation of various types of adult T-cell leukemia. Hematology 22:536\u2013543","journal-title":"Hematology"},{"key":"5556_CR11","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00259-017-3635-2","volume":"44","author":"J Kirchner","year":"2017","unstructured":"Kirchner J, Deuschl C, Grueneisen J et al (2017) (18)F-FDG PET\/MRI in patients suffering from lymphoma: how much MRI information is really needed? Eur J Nucl Med Mol Imaging 44:1005\u20131013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5556_CR12","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2214\/ajr.152.1.175","volume":"152","author":"R Weissleder","year":"1989","unstructured":"Weissleder R, Elizondo G, Stark DD et al (1989) The diagnosis of splenic lymphoma by MR imaging: value of superparamagnetic iron oxide. AJR Am J Roentgenol 152:175\u2013180","journal-title":"AJR Am J Roentgenol"},{"key":"5556_CR13","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1097\/00000478-198909000-00005","volume":"13","author":"JH Krieken van","year":"1989","unstructured":"van Krieken JH, Feller AC, te Velde J (1989) The distribution of non-Hodgkin's lymphoma in the lymphoid compartments of the human spleen. Am J Surg Pathol 13:757\u2013765","journal-title":"Am J Surg Pathol"},{"key":"5556_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1007\/s00292-008-0976-4","volume":"29","author":"A Marx","year":"2008","unstructured":"Marx A, Muller-Hermelink HK, Hartmann M et al (2008) Lymphomas of the spleen. Pathologe 29:136\u2013142","journal-title":"Pathologe"},{"key":"5556_CR15","first-page":"1","volume":"136","author":"S Falk","year":"1991","unstructured":"Falk S (1991) Malignant lymphoma of the spleen. Histological and immunohistochemical studies of morphology and differential diagnosis. Veroff Pathol 136:1\u2013265","journal-title":"Veroff Pathol"},{"key":"5556_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00259-017-3690-8","volume":"44","author":"SF Barrington","year":"2017","unstructured":"Barrington SF, Kluge R (2017) FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas. Eur J Nucl Med Mol Imaging 44:97\u2013110","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5556_CR17","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1097\/00003072-200208000-00005","volume":"27","author":"JN Rini","year":"2002","unstructured":"Rini JN, Manalili EY, Hoffman MA et al (2002) F-18 FDG versus Ga-67 for detecting splenic involvement in Hodgkin's disease. Clin Nucl Med 27:572\u2013577","journal-title":"Clin Nucl Med"},{"key":"5556_CR18","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1148\/rg.301095088","volume":"30","author":"FM Paes","year":"2010","unstructured":"Paes FM, Kalkanis DG, Sideras PA, Serafini AN (2010) FDG PET\/CT of extranodal involvement in non-Hodgkin lymphoma and Hodgkin disease. Radiographics 30:269\u2013291","journal-title":"Radiographics"},{"key":"5556_CR19","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1023\/A:1008377629280","volume":"10","author":"U Rueffer","year":"1999","unstructured":"Rueffer U, Sieber M, Josting A et al (1999) Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: a retrospective analysis of the GHSG. Ann Oncol 10:1343\u20131348","journal-title":"Ann Oncol"},{"key":"5556_CR20","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S0009-9260(05)81766-0","volume":"49","author":"K Sandrasegaran","year":"1994","unstructured":"Sandrasegaran K, Robinson PJ, Selby P (1994) Staging of lymphoma in adults. Clin Radiol 49:149\u2013161","journal-title":"Clin Radiol"},{"key":"5556_CR21","doi-asserted-by":"publisher","unstructured":"Jaffe ES (2009) The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am Soc Hematol Educ Program. https:\/\/doi.org\/10.1182\/asheducation-2009.1.523:523-531","DOI":"10.1182\/asheducation-2009.1.523:523-531"},{"key":"5556_CR22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0033-8389(22)01261-1","volume":"28","author":"A Shirkhoda","year":"1990","unstructured":"Shirkhoda A, Ros PR, Farah J, Staab EV (1990) Lymphoma of the solid abdominal viscera. Radiol Clin N Am 28:785\u2013799","journal-title":"Radiol Clin N Am"},{"key":"5556_CR23","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.3892\/ol.2016.4840","volume":"12","author":"F Shi","year":"2016","unstructured":"Shi F, Zhou Q, Gao Y, Cui XQ, Chang H (2016) Primary splenic B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and classical Hodgkin lymphoma: a case report. Oncol Lett 12:1925\u20131928","journal-title":"Oncol Lett"},{"key":"5556_CR24","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3348\/kjr.2016.17.5.734","volume":"17","author":"JE Lee","year":"2016","unstructured":"Lee JE, Cho JS, Shin KS et al (2016) Diffuse infiltrative splenic lymphoma: diagnostic efficacy of arterial-phase CT. Korean J Radiol 17:734\u2013741","journal-title":"Korean J Radiol"},{"key":"5556_CR25","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1007\/s003300000528","volume":"11","author":"F Robertson","year":"2001","unstructured":"Robertson F, Leander P, Ekberg O (2001) Radiology of the spleen. Eur Radiol 11:80\u201395","journal-title":"Eur Radiol"},{"key":"5556_CR26","first-page":"1072","volume":"44","author":"JN Rini","year":"2003","unstructured":"Rini JN, Leonidas JC, Tomas MB, Palestro CJ (2003) 18F-FDG PET versus CT for evaluating the spleen during initial staging of lymphoma. J Nucl Med 44:1072\u20131074","journal-title":"J Nucl Med"},{"key":"5556_CR27","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1002\/1097-0142(19951015)76:8<1460::AID-CNCR2820760825>3.0.CO;2-Y","volume":"76","author":"R Munker","year":"1995","unstructured":"Munker R, Stengel A, Stabler A, Hiller E, Brehm G (1995) Diagnostic accuracy of ultrasound and computed tomography in the staging of Hodgkin's disease. Verification by laparotomy in 100 cases. Cancer 76:1460\u20131466","journal-title":"Cancer"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-018-5556-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-018-5556-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T06:57:05Z","timestamp":1693724225000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-018-5556-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,18]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["5556"],"URL":"https:\/\/doi.org\/10.1007\/s00330-018-5556-2","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,18]]},"assertion":[{"value":"27 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Prof. Dr. Marius Horger.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"Jan Fritz received institutional research funds and speaker's honorarium from Siemens Healthcare USA and is a scientific advisor of Siemens Healthcare USA and Alexion Pharmaceuticals, IncMarius Horger received institutional research funds and speaker's honorarium from Siemens Healthineers Germany and General Electrics","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"\u2022 retrospective\u2022 case-control study\u2022 performed at one institution","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}